Cite
Improved Survival Among all Interferon-α-Treated Patients in HCV-002, a Veterans Affairs Hepatitis C Cohort of 2211 Patients, Despite Increased Cirrhosis Among Nonresponders.
MLA
Cozen, Myrna, et al. “Improved Survival Among All Interferon-α-Treated Patients in HCV-002, a Veterans Affairs Hepatitis C Cohort of 2211 Patients, Despite Increased Cirrhosis Among Nonresponders.” Digestive Diseases & Sciences, vol. 61, no. 6, June 2016, pp. 1744–56. EBSCOhost, https://doi.org/10.1007/s10620-016-4122-5.
APA
Cozen, M., Ryan, J., Shen, H., Cheung, R., Kaplan, D., Pocha, C., Brau, N., Aytaman, A., Schmidt, W., Pedrosa, M., Anand, B., Chang, K.-M., Morgan, T., Monto, A., Cozen, M. L., Ryan, J. C., Kaplan, D. E., Schmidt, W. N., & Anand, B. S. (2016). Improved Survival Among all Interferon-α-Treated Patients in HCV-002, a Veterans Affairs Hepatitis C Cohort of 2211 Patients, Despite Increased Cirrhosis Among Nonresponders. Digestive Diseases & Sciences, 61(6), 1744–1756. https://doi.org/10.1007/s10620-016-4122-5
Chicago
Cozen, Myrna, James Ryan, Hui Shen, Ramsey Cheung, David Kaplan, Christine Pocha, Norbert Brau, et al. 2016. “Improved Survival Among All Interferon-α-Treated Patients in HCV-002, a Veterans Affairs Hepatitis C Cohort of 2211 Patients, Despite Increased Cirrhosis Among Nonresponders.” Digestive Diseases & Sciences 61 (6): 1744–56. doi:10.1007/s10620-016-4122-5.